OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hederagenin promotes lung cancer cell death by activating CHAC1-dependent ferroptosis pathway
Jiayan Lu, Qixia Guo, Hui Zhao, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 718, pp. 150085-150085
Closed Access | Times Cited: 6
Jiayan Lu, Qixia Guo, Hui Zhao, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 718, pp. 150085-150085
Closed Access | Times Cited: 6
Showing 6 citing articles:
CHAC1: a master regulator of oxidative stress and ferroptosis in human diseases and cancers
Jiasen Sun, Hui Ren, Jiawen Wang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
Jiasen Sun, Hui Ren, Jiawen Wang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
The potential of natural herbal plants in the treatment and prevention of non-small cell lung cancer: An encounter between ferroptosis and mitophagy
Yujie Yang, Bing Jiang, Lijuan Shi, et al.
Journal of Ethnopharmacology (2025), pp. 119555-119555
Closed Access
Yujie Yang, Bing Jiang, Lijuan Shi, et al.
Journal of Ethnopharmacology (2025), pp. 119555-119555
Closed Access
Perfluorooctane sulfonate mediates GSH degradation leading to oral keratinocytes ferroptosis and mucositis through activation of the ER stress-ATF4-CHAC1 axis
Ningning Yang, Kun Jia, Kazuoki Dai, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117964-117964
Open Access
Ningning Yang, Kun Jia, Kazuoki Dai, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 292, pp. 117964-117964
Open Access
Current Progress of Hederagenin and Its Derivatives for Disease Therapy (2017–Present)
Wang Wang, Yan Jin, Mengke Liu, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1275-1275
Open Access
Wang Wang, Yan Jin, Mengke Liu, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1275-1275
Open Access
Hederagenin inhibits mitochondrial damage in Parkinson’s disease via mitophagy induction
Xiaoqian Li, Mengling Hu, Xiaogang Zhou, et al.
Free Radical Biology and Medicine (2024)
Closed Access | Times Cited: 3
Xiaoqian Li, Mengling Hu, Xiaogang Zhou, et al.
Free Radical Biology and Medicine (2024)
Closed Access | Times Cited: 3
Hederagenin ameliorates ferroptosis-induced damage by regulating PPARα/Nrf2/GPX4 signaling pathway in HT22 cells: An in vitro and in silico study
Yuxin Feng, Heran Wang, Yazhuo Hu, et al.
Bioorganic Chemistry (2024) Vol. 155, pp. 108119-108119
Closed Access
Yuxin Feng, Heran Wang, Yazhuo Hu, et al.
Bioorganic Chemistry (2024) Vol. 155, pp. 108119-108119
Closed Access
